ZIVO Bioscience, Inc. (ZIVO)
OTCMKTS
· Delayed Price · Currency is USD
2.070
+0.680 (48.92%)
Apr 28, 2026, 4:00 PM EST
ZIVO Bioscience Employees
ZIVO Bioscience had 7 employees as of December 31, 2024. The number of employees decreased by 1 or -12.50% compared to the previous year.
Employees
7
Change (1Y)
-1
Growth (1Y)
-12.50%
Revenue / Employee
$29,861
Profits / Employee
-$1,212,266
Market Cap
8.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| NKGen Biotech | 26 |
| Brainstorm Cell Therapeutics | 20 |
| Galera Therapeutics | 3 |
| Synlogic | 1 |
| Orgenesis | 77 |
ZIVO Bioscience News
- 4 weeks ago - ZIVO Bioscience Provides Special Letter to Shareholders - Business Wire
- 8 months ago - ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses - Business Wire
- 11 months ago - ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO's Immune-Enhancing Compounds in Poultry - Business Wire
- 1 year ago - University of Delaware Study Identifies Optimal Formulation of ZIVO's Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry - Business Wire
- 1 year ago - ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry - Business Wire
- 1 year ago - ZIVO Bioscience to Present at The Microcap Conference 2025 - Business Wire
- 1 year ago - ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities - Business Wire
- 1 year ago - ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza - Business Wire